| 10-Oct-2025 10:29 |
2.43p |
336,483 |
£8,176 |
Sell |
O |
| 10-Oct-2025 12:20 |
2.43p |
300,000 |
£7,290 |
Sell |
O |
| 10-Oct-2025 12:57 |
2.38p |
60,000 |
£1,428 |
Buy |
O |
| 10-Oct-2025 08:39 |
2.43p |
45,000 |
£1,094 |
Sell |
O |
| 10-Oct-2025 12:57 |
2.38p |
42,710 |
£1,016 |
Buy |
O |
| 10-Oct-2025 09:50 |
2.43p |
15,538 |
£378 |
Sell |
O |
| 10-Oct-2025 08:18 |
2.43p |
8,836 |
£215 |
Sell |
O |
| 10-Oct-2025 11:39 |
2.50p |
4,000 |
£100 |
Sell |
O |
| 10-Oct-2025 08:04 |
2.53p |
3,519 |
£89 |
Buy |
O |
| 10-Oct-2025 08:20 |
2.43p |
113 |
£3 |
Sell |
O |
| 16:04 |
50,000 @ 1.80p |
| 15:25 |
230,672 @ 1.72p |
| 15:08 |
53 @ 1.90p |
| 14:38 |
79,079 @ 1.73p |
| 09:49 |
40,000 @ 1.72p |
| CEO |
James Sheehan |
| CFO |
Daniel Maling |
Top of Page
You are here:
research